Abstract

Conducting anticoagulant therapy for atrial fibrillation, combined with diabetes mellitus and/or chronic kidney disease, can create certain difficulties for practicing doctors due to a simultaneous increase in the risk of thromboembolic and hemorrhagic complications. The presence of diabetes mellitus and renal dysfunction can influence the results of antithrombotic therapy in patients with atrial fibrillation. The review provides information on the differences in efficacy and safety of individual oral anticoagulants in the prevention of thromboembolic complications of atrial fibrillation in patients with diabetes mellitus, impaired renal function.

Highlights

  • В последние годы среди населения развитых стран мира отмечается прогрессивное увеличение распространенности фибрилляции предсердий (ФП) и СД, поз­ воляющее констатировать настоящую неинфекционную пандемию [1, 2]

  • renal dysfunction can influence the results of antithrombotic therapy in patients

  • нарушение эндотелиальной функции во многом объясняют связь между СД и обусловленным

Read more

Summary

Summary

Conducting anticoagulant therapy for atrial fibrillation, combined with diabetes mellitus and / or chronic kidney disease, can create certain difficulties for practicing doctors due to a simultaneous increase in the risk of thromboembolic and hemorrhagic complica‐ tions. The presence of diabetes mellitus and renal dysfunction can influence the results of antithrombotic therapy in patients with atrial fibrillation. The review provides information on the differences in efficacy and safety of individual oral anticoagulants in the pre‐ vention of thromboembolic complications of atrial fibrillation in patients with diabetes mellitus, impaired renal function. СД является независимым ФР развития инсульта и других осложнений у пациентов с ФП [6]. Все это заставляет уделять особое внимание проведению профилактики тромбоэмболических осложнений при сочетании ФП и СД

Антикоагулянтная терапия при сочетании ФП и СД
Антикоагулянтная терапия при сочетании ФП и хронической болезни почек

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.